Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02582034
What this trial is testing

Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard Dosimetry

Who this might be right for
Adenoma, Liver Cell
Center Eugene Marquis 56
Not applicableStudy completedNCT02040155
What this trial is testing

Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy

Who this might be right for
Cancer of the Cervix, Cancer of the Endometrium
Duke University 16
Early research (Phase 1)Ended earlyNCT00747825
What this trial is testing

Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Molecular Insight Pharmaceuticals, Inc. 12
Early research (Phase 1)Study completedNCT01307852
What this trial is testing

In Vivo Dosimetry During Prostate Cancer Radiotherapy

Who this might be right for
Prostate Disease
M.D. Anderson Cancer Center 7
Early research (Phase 1)WithdrawnNCT04632199
What this trial is testing

Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer.

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal Cancer
Ipsen
Early research (Phase 1)Looking for participantsNCT07416552
What this trial is testing

Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Hoffmann-La Roche 180
Not applicableStudy completedNCT03002116
What this trial is testing

Microwave Radiometry Thermometry for the Diagnosis of Critical Limb Ischemia in Diabetic Patients

Who this might be right for
Diabetic FootPeripheral Arterial DiseaseIschaemic Neuropathy
Attikon Hospital 80
Not applicableStudy completedNCT03295006
What this trial is testing

A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 209
Not applicableStudy completedNCT06224309
What this trial is testing

Preliminary Assessment of [18F]BL40 in PET/CT Scans

Who this might be right for
Diffuse Large B-cell LymphomaMultiple MyelomaMantle Cell Lymphoma+3 more
British Columbia Cancer Agency 10
Not applicableLooking for participantsNCT00001160
What this trial is testing

Studies on Tumors of the Thyroid

Who this might be right for
Hurthle Cell Thyroid CancerTall Cell Variant Thyroid CancerFollicular Thyroid Cancer+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2,500
Post-approval studies (Phase 4)Study completedNCT00882596
What this trial is testing

Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients

Who this might be right for
Breast Cancer
Cancer Center of Irvine 30
Not applicableStudy completedNCT03109262
What this trial is testing

Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors

Who this might be right for
Primary Malignant Liver Neoplasm
Stanford University 42
Early research (Phase 1)UnknownNCT00003920
What this trial is testing

Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of California, Davis 18
Early research (Phase 1)Study completedNCT00733460
What this trial is testing

A Phase I Study to Evaluate BFPET as a Potential Myocardial Perfusion Imaging(MPI) Agent for PET

Who this might be right for
Coronary Artery Disease
Fluoropharma, Inc. 12
Early research (Phase 1)Looking for participantsNCT07537010
What this trial is testing

3D1015 Injection for Patients With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, mCRPC
Chunjing Yu 8
Not applicableWithdrawnNCT00756691
What this trial is testing

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

Who this might be right for
Hypoxic Tumours
AHS Cancer Control Alberta
Early research (Phase 1)WithdrawnNCT03241446
What this trial is testing

Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis (RA)

Who this might be right for
Arthritis, Rheumatoid
Navidea Biopharmaceuticals
Not applicableStudy completedNCT02865837
What this trial is testing

Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer

Who this might be right for
Cervical Cancer
Institut de Cancérologie de Lorraine 22
Not applicableStudy completedNCT01373944
What this trial is testing

Efficiency and Outcomes of Stress-Only Anger and D-SPECT Stress-Only SPECT MPI

Who this might be right for
Coronary Artery Disease
Aspire Foundation 500
Testing effectiveness (Phase 2)Looking for participantsNCT06549465
What this trial is testing

Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
PSMA PET-Positive Castration-Resistant Prostate Cancer
Convergent Therapeutics 93
Next Page